Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

Details for Australian Patent Application No. 2004207535 (hide)

Owner Elan Pharmaceuticals Inc.

Inventors Karlik, Steve J.; Pleiss, Michael A.; Konradi, Andrei W.; Grant, Francine S.; Semko, Christopher M.; Dressen, Daren; Messersmith, Elizabeth; Freedman, Stephen; Yednock, Ted

Agent Mallesons

Pub. Number AU-A-2004207535

PCT Pub. Number WO2004/066931

Priority 60/442,171 24.01.03 US; 60/500,316 05.09.03 US

Filing date 26 January 2004

Wipo publication date 12 August 2004

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/066931 Priority application(s): WO2004/066931

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004207536-Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

2004207534-Defibrillation system for non-medical environments